Inactive Instrument
NicOx SA Share Price Euronext Paris
Stocks
NCOX
FR0000074130
Pharmaceuticals
OTC Markets Traded| Market Cap | 2.91Cr 3.34Cr 2.75Cr 2.5Cr 4.68Cr 320.52Cr 4.7Cr 33Cr 13Cr 162.95Cr 13Cr 12Cr 524.33Cr | P/E 2026 * |
-6.61x | P/E 2027 * | 16.5x |
|---|---|---|---|---|---|
| Enterprise Value | 2.91Cr 3.34Cr 2.75Cr 2.5Cr 4.68Cr 320.52Cr 4.7Cr 33Cr 13Cr 162.95Cr 13Cr 12Cr 524.33Cr | EV / Sales 2026 * |
9.71x | EV / Sales 2027 * | 2.91x |
| Free-Float |
99.65% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -7.95% |
| Manager | Title | Age | Since |
|---|---|---|---|
Gavin Spencer
CEO | Chief Executive Officer | 55 | 28/02/2024 |
Sandrine Gestin
DFI | Director of Finance/CFO | 58 | 01/01/2015 |
Emmet Purtill
PRN | Corporate Officer/Principal | - | 01/01/2006 |
| Director | Title | Age | Since |
|---|---|---|---|
Gavin Spencer
BRD | Director/Board Member | 55 | 08/04/2024 |
Damian Marron
CHM | Chairman | 64 | 16/07/2024 |
Marc Bozec
BRD | Director/Board Member | - | 16/07/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -7.95% | -9.39% | - | - | 3.34Cr | |
| -0.36% | +1.85% | +79.80% | +35.96% | 36TCr | |
| -1.22% | -1.22% | +20.85% | -19.25% | 6.56TCr | |
| +2.21% | +4.70% | +46.37% | +186.99% | 1.24TCr | |
| -0.29% | +2.27% | -5.37% | -16.54% | 760.29Cr | |
| -1.89% | -6.83% | -27.65% | -14.90% | 449.16Cr | |
| -2.06% | -3.80% | -34.68% | +5.56% | 418.7Cr | |
| +1.48% | +2.36% | -31.20% | -13.91% | 291.9Cr | |
| -2.25% | +1.39% | -8.48% | +49.13% | 249.48Cr | |
| -0.41% | -0.71% | -28.25% | -33.78% | 193.24Cr | |
| Average | -1.30% | +0.50% | +1.27% | +19.92% | 5.16TCr | |
| Weighted average by Cap. | -0.46% | +1.38% | +65.50% | +30.05% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 30L 34.4L 28.33L 25.72L 48.19L 33Cr 48.4L 3.39Cr 1.31Cr 17Cr 1.29Cr 1.26Cr 54Cr | 1Cr 1.15Cr 94.42L 85.74L 1.61Cr 110.04Cr 1.61Cr 11Cr 4.36Cr 56Cr 4.31Cr 4.21Cr 180.01Cr |
| Net income | -50L -57.34L -47.21L -42.87L -80.32L -55Cr -80.66L -5.66Cr -2.18Cr -28Cr -2.15Cr -2.11Cr -90Cr | 20L 22.94L 18.88L 17.15L 32.13L 22Cr 32.26L 2.26Cr 87.29L 11Cr 86.16L 84.25L 36Cr |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals
